APA (7th ed.) Citation

Voskaridou, E., Ntanasis-Stathopoulos, I., Christoulas, D., Dimopoulou, M., Komninaka, V., Repa, K., . . . Terpos, E. (2019). Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density. Annals of Hematology, 98(7), 1583. https://doi.org/10.1007/s00277-019-03695-x

Chicago Style (17th ed.) Citation

Voskaridou, Ersi, Ioannis Ntanasis-Stathopoulos, Dimitrios Christoulas, Maria Dimopoulou, Veroniki Komninaka, Konstantina Repa, Athanasios Papatheodorou, and Evangelos Terpos. "Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle Cell/beta-thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density." Annals of Hematology 98, no. 7 (2019): 1583. https://doi.org/10.1007/s00277-019-03695-x.

MLA (9th ed.) Citation

Voskaridou, Ersi, et al. "Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle Cell/beta-thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density." Annals of Hematology, vol. 98, no. 7, 2019, p. 1583, https://doi.org/10.1007/s00277-019-03695-x.